An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

Alcohol interventions in a trauma center as a means of reducing the risk of injury recurrence. Ann Surg (1999) 4.84

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75

Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction (2011) 2.58

Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"? Health Serv Res (2006) 2.14

Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry (2007) 2.07

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97

Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci (2004) 1.96

Matching Judicial Supervision to Clients' Risk Status in Drug Court. Crime Delinq (2006) 1.81

Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry (2008) 1.76

The Important People Drug and Alcohol interview: psychometric properties, predictive validity, and implications for treatment. J Subst Abuse Treat (2008) 1.68

Predictors of medication adherence among HIV-infected youth. Psychol Health Med (2005) 1.68

Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses. Addiction (2011) 1.68

Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) (2008) 1.67

Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend (2009) 1.63

Early identification of alcohol problems. CMAJ (1990) 1.59

The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend (2007) 1.54

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health (2004) 1.54

Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis (2006) 1.52

A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes. J Consult Clin Psychol (2010) 1.50

Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain (2010) 1.50

Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Depend (2005) 1.50

The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc (2010) 1.49

Sleep disturbance in heavy marijuana users. Sleep (2008) 1.49

Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. Health Serv Res (2002) 1.48

Behavioral outcome of preschoolers exposed prenatally to cocaine: role of maternal behavioral health. J Pediatr Psychol (2002) 1.47

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther (2004) 1.46

Project QUIT (Quit Using Drugs Intervention Trial): a randomized controlled trial of a primary care-based multi-component brief intervention to reduce risky drug use. Addiction (2015) 1.45

The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction. Subst Abuse Rehabil (2012) 1.44

Racial and ethnic service use disparities among homeless adults with severe mental illnesses receiving ACT. Psychiatr Serv (2011) 1.43

Adapting judicial supervision to the risk level of drug offenders: discharge and 6-month outcomes from a prospective matching study. Drug Alcohol Depend (2006) 1.41

An obese body mass increases the adverse effects of HIV/AIDS on balance and gait. Phys Ther (2011) 1.41

Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39

Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. J Nerv Ment Dis (2009) 1.37

Improving public addiction treatment through performance contracting: the Delaware experiment. Health Policy (2008) 1.36

Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35

Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33

Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev (2010) 1.32

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry (2013) 1.32

Welfare reform and substance abuse. Milbank Q (2005) 1.31

Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J (2011) 1.28

Prenatal cocaine exposure and gray matter volume in adolescent boys and girls: relationship to substance use initiation. Biol Psychiatry (2013) 1.27

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. Biol Psychiatry (2012) 1.27

Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project. Eval Program Plann (2008) 1.27

Just say "I don't": lack of concordance between teen report and biological measures of drug use. Pediatrics (2010) 1.26

Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment. Clin Psychol (New York) (2012) 1.26

Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug Alcohol Depend (2011) 1.26

Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry (2008) 1.25

Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am J Addict (2009) 1.24

Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology (2008) 1.23

Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol (2011) 1.23

Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction (2011) 1.22

Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care STDS (2009) 1.22

Service system integration, access to services, and housing outcomes in a program for homeless persons with severe mental illness. Am J Public Health (1998) 1.22

Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry (2008) 1.21

Service delivery and community: social capital, service systems integration, and outcomes among homeless persons with severe mental illness. Health Serv Res (2001) 1.21

Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial. Trials (2011) 1.19

Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS (2009) 1.19

Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr Bull (2006) 1.18

A study of problem drinkers in a general hospital. Indian J Psychiatry (1997) 1.17

The mental health experiences and needs of methamphetamine users in Cape Town: A mixed methods study. S Afr Med J (2015) 1.16

Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS One (2011) 1.16

Client and program factors associated with dropout from court mandated drug treatment. Eval Program Plann (2008) 1.14

Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health (1997) 1.10

Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. J Acquir Immune Defic Syndr (2011) 1.09

Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response. PLoS One (2011) 1.08

Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend (2010) 1.08

Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol (2008) 1.08

A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addict Behav (2009) 1.07

Responses to novelty and vulnerability to cocaine addiction: contribution of a multi-symptomatic animal model. Cold Spring Harb Perspect Med (2012) 1.07

Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse (2010) 1.07

Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav (2013) 1.07

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull (2006) 1.07

A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res (2009) 1.06

Outcomes of drug and alcohol treatment programs among American Indians in California. Am J Public Health (2006) 1.06

Assessing addiction: concepts and instruments. Addict Sci Clin Pract (2007) 1.06

Enhancing validity in co-occurring disorders treatment research. Schizophr Bull (2006) 1.06

Measuring addiction propensity and severity: the need for a new instrument. Drug Alcohol Depend (2010) 1.05

Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Ment Health J (1997) 1.05

Comparison of opiate-primary treatment seekers with and without alcohol use disorder. J Subst Abuse Treat (2010) 1.05

Substance use and the quality of patient-provider communication in HIV clinics. AIDS Behav (2011) 1.05

Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine. Psychopharmacology (Berl) (2011) 1.05

Impact of supported housing on clinical outcomes: analysis of a randomized trial using multiple imputation technique. J Nerv Ment Dis (2007) 1.04

Prenatal drug exposure and maternal and infant feeding behaviour. Arch Dis Child Fetal Neonatal Ed (2003) 1.04

Recent status scores for version 6 of the Addiction Severity Index (ASI-6). Addiction (2011) 1.04

Prenatal cocaine exposure, gender, and adolescent stress response: a prospective longitudinal study. Neurotoxicol Teratol (2010) 1.04

Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend (2013) 1.03

Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology (2013) 1.03

Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. J Stud Alcohol Drugs (2008) 1.03

A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine. AIDS Patient Care STDS (2012) 1.03

Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Drug Alcohol Depend (2012) 1.02

Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr (2011) 1.02

Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS Behav (2013) 1.01

Overrepresentation of women veterans among homeless women. Am J Public Health (2003) 1.01

Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend (2011) 1.01

The effect of social desirability on reported motivation, substance use severity, and treatment attendance. J Subst Abuse Treat (2011) 1.00

The Dynamic Assessment and Referral System for Substance Abuse (DARSSA): development, functionality, and end-user satisfaction. Drug Alcohol Depend (2008) 1.00

Decision-making role preferences among patients with HIV: associations with patient and provider characteristics and communication behaviors. J Gen Intern Med (2010) 1.00

Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet (2010) 1.00

Randomized clinical trial of the effects of screening and brief intervention for illicit drug use: the Life Shift/Shift Gears study. Addict Sci Clin Pract (2014) 1.00

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 14.17

New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis (1985) 9.12

Limbic activation during cue-induced cocaine craving. Am J Psychiatry (1999) 6.66

The effects of psychosocial services in substance abuse treatment. JAMA (1993) 5.87

Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry (1992) 5.48

Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr (1993) 5.08

A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis (1992) 4.64

Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry (1999) 4.22

The economic costs of heroin addiction in the United States. Drug Alcohol Depend (2001) 2.90

The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89

Drug abuse treatment as AIDS prevention. Public Health Rep (1998) 2.80

Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses (1994) 2.62

Myths about the treatment of addiction. Lancet (1996) 2.58

The role of the therapeutic alliance in psychotherapy. J Consult Clin Psychol (1993) 2.45

Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J Consult Clin Psychol (1994) 2.31

Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) (1992) 2.29

Classical conditioning in drug-dependent humans. Ann N Y Acad Sci (1992) 2.28

Brain activity during simulated deception: an event-related functional magnetic resonance study. Neuroimage (2002) 2.26

Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry (1983) 2.25

Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr (1993) 2.23

A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat (1998) 2.15

Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med (1989) 2.11

Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry (1997) 2.07

Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence. J Consult Clin Psychol (1998) 2.01

Therapist success and its determinants. Arch Gen Psychiatry (1985) 2.00

Comparative studies of psychotherapies. Is it true that "everywon has one and all must have prizes"? Arch Gen Psychiatry (1975) 2.00

Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat (1998) 1.98

Problem-service 'matching' in addiction treatment. A prospective study in 4 programs. Arch Gen Psychiatry (1997) 1.96

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) Arch Gen Psychiatry (1999) 1.94

Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. J Consult Clin Psychol (1996) 1.81

Are supplementary services provided during methadone maintenance really cost-effective? Am J Psychiatry (1997) 1.81

A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend (1999) 1.78

Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons. Milbank Q (1996) 1.78

Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict (1986) 1.69

Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat (2001) 1.68

Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav (1996) 1.66

Anonymous HIV testing using home collection and telemedicine counseling. A multicenter evaluation. Arch Intern Med (1997) 1.64

Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend (1999) 1.64

Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis (2000) 1.62

Reliability and validity of the Addiction Severity Index with a homeless sample. J Subst Abuse Treat (1995) 1.60

Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict Behav (1992) 1.57

Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction (2001) 1.56

Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res Monogr (1988) 1.56

The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Arch Gen Psychiatry (1997) 1.56

Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend (1994) 1.53

Increase in desipramine serum levels associated with methadone treatment. Am J Psychiatry (1989) 1.53

Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. J Consult Clin Psychol (1995) 1.52

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) (1997) 1.49

Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry (1995) 1.49

Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis? Am J Psychiatry (1990) 1.48

Use of disulfiram for alcoholics in methadone maintenance programs. A Veterans Administration Cooperative Study. Arch Gen Psychiatry (1983) 1.47

Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict (2001) 1.46

Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry (1996) 1.43

Psychotherapy for opiate addicts. Does it help? Arch Gen Psychiatry (1983) 1.42

Therapeutic alliance as a predictor of outcome and retention in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. J Consult Clin Psychol (2001) 1.41

Progress in the science of addiction. Am J Psychiatry (1997) 1.41

Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav (2001) 1.41

Increased effectiveness of substance abuse treatment. A prospective study of patient-treatment "matching". J Nerv Ment Dis (1983) 1.40

One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend (1998) 1.39

Conditioned craving and arousal in cocaine addiction: a preliminary report. NIDA Res Monogr (1988) 1.38

Addiction severity index data from general membership and treatment samples of HMO members. One case of norming the ASI. J Subst Abuse Treat (2000) 1.37

Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl (2000) 1.34

Multidimensional assessment of perceived treatment-entry pressures among substance abusers. Psychol Addict Behav (2001) 1.34

Crack cocaine abuse: an epidemic with many public health consequences. Annu Rev Public Health (1996) 1.34

Is the counselor an "active ingredient" in substance abuse rehabilitation? An examination of treatment success among four counselors. J Nerv Ment Dis (1988) 1.33

Two helping alliance methods for predicting outcomes of psychotherapy. A counting signs vs. a global rating method. J Nerv Ment Dis (1983) 1.32

Sociopathy and psychotherapy outcome. Arch Gen Psychiatry (1985) 1.31